A drug to treat advanced prostate cancer should be given to patients on the NHS, a health watchdog has said.
Abirateron, marketed as Zytiga, can extend the lives of late-stage cancer sufferers by more than three months.
The National Institute for Health and Clinical Excellence (Nice) revised its recommendations after fresh information from manufacturer Janssen, and the new draft guidance was welcomed by experts.
More top news
Thousands of people are staying in temporary shelters following the big earthquake in Indonesia's Aceh province.
Russia appears to have snubbed a Japanese attempt at puppy-love diplomacy by declining a gift of a dog for President Vladimir Putin.
The self-declared white supremacist's was recorded telling an FBI agent "I went to that church in Charleston and I did it."